Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004612 |
ID: | TCMBANKHE004612 |
植物拉丁名: |
|
功能与主治: | To replenish the liver, to cause tranquilizations to arrest excessive perspiration, and to promote the production of body fluid./Neurasthenia, vacuity vexation and insomnia, fright palpitation, arrhythmia, frequent dreaming, vacuity and profuse sweating, fluid damage and thirst. |
药用植物名: | 酸枣仁 |
药用部位: | seed |
药味: | Mild; Sweet; Sour |
经络: | Spleen; Liver; Heart; Gallbladder |
临床特征: | The chief components are jujuboside A and B. 1. Intraperitoneal injection its decoction ( 2.5-5.0g/kg ) exerts sedative and hypnotic effects in rats. 2. Intravenous injection of its decoction exerts significant and proloned hypotensive effect in anestheti |
治疗类型: | 安神药 |
TCM_ID_id: | 6272 |
SymMap_id: | 386 |
TCMSP_id: | 678 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000040 | jujuboside a | jujuboside A; JuA; Jujuboside A1; 2-[(4-{[4,5-DIHYDROXY-6-({[3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}METHYL)-3-[(3,4,5-TRIHYDROXYOXAN-2-YL)OXY]OXAN-2-YL]OXY}-5-HYDROXY-2-{[16-HYDROXY-2,6,6,10,16-PENTAMETHYL-18-(2-METHYLPROP-1-EN-1-YL)-19,21-DIOXAHEXACYCLO[18.2.1.0(1),(1)?.0(2),(1)(1).0?,(1)?.0(1)?,(2)?]TRICOSAN-7-YL]OXY}OXAN-3-YL)OXY]-6-METHYLOXANE-3,4,5-TRIOL; 2-[(4-{[4,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}-5-hydroxy-2-{[16-hydroxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0;{1,14}.0;{2,11}.0;{5,10}.0;{15,20}]tricosan-7-yl]oxy}oxan-3-yl)oxy]-6-methyloxane-3,4,5-triol | C58H94O26 | 1207.3 g/mol | CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC6C7C(CC(OC78CC6(C5(CCC4C3(C)C)C)CO8)C=C(C)C)(C)O)C)O)OC9C(C(C(C(O9)COC1C(C(C(C(O1)CO)O)O)O)O)O)OC1C(C(C(CO1)O)O)O)O)O)O |
| TCMBANKIN000639 | Convallasaponin A | convallasaponin a | C32H52O9 | 580.75 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6(C5(C(CC(C6)OC7C(C(C(CO7)O)O)O)O)C)O)C)C)OC1 |
| TCMBANKIN001365 | julibrogenin a | 5,10-dihydroxy-3-[(2Z)-2-(hydroxymethyl)-6-methoxy-6-methylocta-2,7-dienoyl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; AC1NSX84 | C41H64O8 | CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CC(C2(CC1OC(=O)C(=CCCC(C)(C=C)OC)CO)C(=O)O)O)C)C)(C)C)O)C)C | |
| TCMBANKIN002881 | zivulgarin | LMPK12110986 | C28H32O15 | 608.54 | COC1=C(C(=C2C(=C1)OC(=CC2=O)C3=CC=C(C=C3)O)O)C4C(C(C(C(O4)CO)OC5C(C(C(C(O5)CO)O)O)O)O)O |
| TCMBANKIN002897 | 6-Fluoroindole-7-Dehydrocholesterol | 402.7 | |||
| TCMBANKIN003230 | sanjoinine A | C31H42N4O4 | 534.69 | ||
| TCMBANKIN003885 | Sinapyl alcohol | 404586_ALDRICH; Sinapic alcohol; Phenol, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxy-; Sinapoyl alcohol; 4-(3-hydroxyprop-1-enyl)-2,6-dimethoxyphenol; 4-(3-hydroxyprop-1-enyl)-2,6-dimethoxy-phenol; 4-Hydroxy-3,5-dimethoxycinnamyl alcohol; 4-[(E)-3-hydroxyprop-1-enyl]-2,6-dimethoxy-phenol; sinapyl alcohol; 537-33-7; 4-[(E)-3-hydroxyprop-1-enyl]-2,6-dimethoxyphenol; 2-Propen-1-ol, 3-(4-hydroxy-3,5-dimethoxyphenyl), (E)-; ST069367; CHEBI:28813; C02325; 4-(3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenol; InChI=1/C11H14O4/c1-14-9-6-8(4-3-5-12)7-10(15-2)11(9)13/h3-4,6-7,12-13H,5H2,1-2H3/b4-3; Sinapyl alcohol, (E) | C11H14O4 | 210.23 | COC1=CC(=CC(=C1O)OC)C=CCO |
| TCMBANKIN005805 | acetyljujuboside b | C54H86O22 | 1087.2 g/mol | CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC6C7C(CC(OC78CC6(C5(CCC4C3(C)C)C)CO8)C=C(C)C)(C)O)C)O)OC9C(C(C(C(O9)COC(=O)C)O)O)OC1C(C(C(CO1)O)O)O)O)O)O | |
| TCMBANKIN006853 | dl-Nuciferine | Aprphine, 1,2-dimethoxy-, (+-)-; 1,2-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline; (+-)-1,2-Dimethoxyaporphine; InChI=1/C19H21NO2/c1-20-9-8-13-11-16(21-2)19(22-3)18-14-7-5-4-6-12(14)10-15(20)17(13)18/h4-7,11,15H,8-10H2,1-3H; 5868-18-8; 4H-dibenzo[de,g]quinoline, 5,6,6a,7-tetrahydro-1,2-dimethoxy-6-methyl-; APORPHINE, 1,2-DIMETHOXY-; 4H-Dibenzo(de,g)quinoline, 5,6,6a,7-tetrahydro-1,2-dimethoxy-6-methyl-, (+-)- (9CI) | C19H21NO2 | 295.38 | CN1CCC2=CC(=C(C3=C2C1CC4=CC=CC=C43)OC)OC |
| TCMBANKIN007802 | zivulgarin_qt | C28H32O15 | 608.54 | ||
| TCMBANKIN008931 | ebractelatinoside b | AC1NSUZQ; 1-[3-[[3-acetyl-2-hydroxy-4-methoxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-2,4-dihydroxy-6-methoxyphenyl]ethanone | C25H30O13 | CC(=O)C1=C(C(=C(C=C1OC)O)CC2=C(C=C(C(=C2O)C(=O)C)OC)OC3C(C(C(C(O3)CO)O)O)O)O | |
| TCMBANKIN009263 | 6'-p-coumaroylspinosin | [(2R,3S,4S,5R,6S)-6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-2-[5-hydroxy-2-(4-hydroxyphenyl)-7-methyl-4-oxochromen-6-yl]-6-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; AC1NSTWM | C37H38O17 | 768.78 | |
| TCMBANKIN009889 | (?)-caaverine | C17H17NO2 | COC1=C(C2=C3C(CC4=CC=CC=C42)NCCC3=C1)O | ||
| TCMBANKIN010488 | juzirine | AC1MJ48I; Juzirine; 7-Hydroxy-1-(4-hydroxybenzyl)-6-methoxyisoquinoline; 7-hydroxy-1-(4'-hydroxybenzyl)-6-methoxyisoquinoline; J3.620.994A; 64069-53-0; 1-((4-Hydroxyphenyl)methyl)-6-methoxy-7-isoquinolinol; DTXSID20214263; 7-Isoquinolinol, 1-((4-hydroxyphenyl)methyl)-6-methoxy-; 1-(4-Hydroxybenzyl)-6-methoxyisoquinoline-7-ol; 1-[(4-hydroxyphenyl)methyl]-6-methoxyisoquinolin-7-ol | C17H15NO3 | 281.3 g/mol | COC1=C(C=C2C(=C1)C=CN=C2CC3=CC=C(C=C3)O)O |
| TCMBANKIN012429 | methylazoxymethanol | 590-96-5; 1-Hydroxymethyl-2-methylditmide-2-oxide; (Z)-hydroxymethylimino-methyl-oxidoazanium; CCRIS 1113; C02390; (methyl-ONN-azoxy)methanol; METHYLAZOXYMETHANOL; HSDB 3509; AC1O5FSF; UNII-JGG19N3YDQ; Methanol, (methyl-ONN-azoxy)-; methyl-ONN-azoxymethanol; CHEBI:29323; BRN 1921057; JGG19N3YDQ; CH3-N(O)=N-CH2OH | C2H6N2O2 | 90.08 g/mol | C[N+](=NCO)[O-] |
| TCMBANKIN012700 | coumestrol | NCIMech_000078; CCRIS 7311; A-Lactone; API0002121; Tox21_200032; MolPort-003-846-031; US8552057, 3; HMS3374A07; 3,9-Dihydroxy-6H-benzofuro[3,2-c]-[1]benzopyran-6-one; 6H-Benzofuro[3,2-c][1]benzopyran-6-one,3,9-dihydroxy-; Cumostrol; CHEBI:3908; C-16836; VZ31590; LS-35394; S00280; 3,9-dihydroxy-[1]benzofuro[3,2-c]chromen-6-one; MFCD00016885; SMP2_000163; DSSTox_RID_76572; 27885_FLUKA; 6H-Benzofuro[3, 3,9-dihydroxy-; 5-19-06-00405 (Beilstein Handbook Reference); BRN 0266702; 479-13-0; NSC22842; 3-Benzofurancarboxylic acid, 2-(2,4-dihydroxyphenyl)-6-hydroxy-, delta-lactone; C10205; 3,9-dihydroxy-[1]benzoxolo[3,2-c]chromen-6-one; AC1NQYXV; 3-Benzofurancarboxylic acid, 2-(2,4-dihydroxyphenyl)-6-hydroxy-, delta-lactone (6CI); NCGC00018124-01; DSSTox_CID_2399; CTK8F8799; Coumestrol, >=95.0% (HPLC); NCI60_001863; 4CN-2508; ZZIALNLLNHEQPJ-UHFFFAOYSA-N; BIDD:ER0114; NCGC00018124-03; 3,9-Dihydroxy-6H-[1]benzofuro[3,2-c]chromen-6-one #; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihydroxy-; A1-00298; NSC 22842; 3,9-Dihydroxy-6H-benzofuro(3,2-c)(1)benzopyran-6-one; CCG-35536; NCGC00018124-06; 3,9-bis(oxidanyl)-[1]benzofuro[3,2-c]chromen-6-one; ZINC1219; NCGC00257586-01; 3,9-Dihydroxy-benzo[4,5]furo[3,2-c]chromen-6-one; AIDS011954; SCHEMBL22012; UNII-V7NW98OB34; 3-Benzofurancarboxylic acid, 2-(2,4-dihydroxyphenyl)-6-hydroxy-, .delta.-lactone; 6H-Benzofuro[3,2-c][1]benzopyran-6-one, 3,9-dihydroxy-; MLS000069446; CCG-36200; LMPK12090018; 3-Benzofurancarboxylic acid,4-dihydroxyphenyl)-6-hydroxy-, .delta.-lactone; 7,12-Dihydroxycoumestan; CS-6343; D02DML; CHEMBL30707; 3,9-dihydroxy-6-benzofurano[3,2-c]chromenone; ZINC00001219; 5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one; Oprea1_222511; MLS000738006; EINECS 207-525-6; 3,9-Dihydroxycoumestan; Coumestrol, BioReagent, suitable for fluorescence, >=97.5% (HPLC); A827386; DTXSID6022399; CAS-479-13-0; FT-0603177; ST50320052; 2-(2,4-Dihydroxyphenyl)-6-hydroxy-3-benzofurancarboxylic Acid ; 3,9-dihydroxybenzofurano[3,2-c]chromen-6-one; 3,9-dihydroxybenzo[d]chromeno[4,3-b]furan-6-one; NCGC00023462-03; AIDS-011954; V0359; Cumoestrol; DSSTox_GSID_22399; Cumoesterol; NCGC00018124-05; Coumestrol; NCGC00018124-04; V7NW98OB34; ZB000278; 3,9-Dihydroxy-6H-[1]benzofuro[3,2-c]chromen-6-one; ST5320052; AN-6463; Cumestrol; NCGC00023462-04; NCGC00018124-02; CC-25990; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihdyroxy-; NSC-22842; 3,9-dihydroxybenzofuro[3,2-c]chromen-6-one; AKOS028111776; HMS2235B05; Coumesterol; COUMESTROL; BDBM23451; SMR000059001; HY-N2335; 27883_FLUKA | C15H8O5 | 268.22 | C1=CC2=C(C=C1O)OC3=C2C(=O)OC4=C3C=CC(=C4)O |
| TCMBANKIN013261 | ceanothic acid | NCGC00168838-03_C30H46O5_(1R,2S,5aR,5bR,7aS,10R,12bR)-2-Hydroxy-10-isopropenyl-3,3,5a,5b,12b-pentamethyloctadecahydrodicyclopenta[a,i]phenanthrene-1,7a(1H)-dicarboxylic acid; (1R,2R,5S,8R,14R,15R,16S)-16-HYDROXY-1,2,14,17,17-PENTAMETHYL-8-(PROP-1-EN-2-YL)PENTACYCLO[11.7.0.0(2),(1)?.0?,?.0(1)?,(1)?]ICOSANE-5,15-DICARBOXYLIC ACID; ACon0_000328; ACon1_000054; MolPort-001-741-019; ceanothicacid; NCGC00168838-01; NP-002508; MEGxp0_000866 | C30H46O5 | 486.68 | CC(=C)C1CCC2(C1C3CCC4C(C3(CC2)C)(CCC5C4(C(C(C5(C)C)O)C(=O)O)C)C)C(=O)O |
| TCMBANKIN014614 | jujuboside b | jujuboside B; DTXSID80670023; AKOS015965496; Jujuboside-B; JujubosideB; AN-40319; PUBCHEM_45358134; AC-20265 | C52H84O21 | 1045.2 g/mol | CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC6C(C5(CCC4C3(C)C)C)CC78C6C(CC(O7)(OC8)C=C(C)C)(C)O)C)O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(CO1)O)O)O)O)O)O |
| TCMBANKIN016847 | Sylvestrene | 499-03-6; 1-METHYL-3-(PROP-1-EN-2-YL)CYCLOHEX-1-ENE; 1-Methyl-3-(1-methylethenyl)cyclohexene (+-)-; 1-methyl-3-(1-methylethenyl)cyclohexene; 3-Isopropenyl-1-methylcyclohexene; m-Mentha-1,8-diene, (.+/-.)-; A23140; 1-methyl-3-prop-1-en-2-ylcyclohexene; Cyclohexene, 1-methyl-3-(1-methylethenyl)-, (.+/-.)-; AC1Q2A53; Carvestren; m-Mentha-1,8-diene; Cyclohexene, 1-methyl-3-(1-methylethenyl)-; UXZIDIYMFIBDKT-UHFFFAOYSA-N; Carvestrene; sylvestrene; (+-)-Isosylvestrene; AC1L1V0T; 38738-60-2; 3-Isopropenyl-1-methyl-1-cyclohexene #; (+-)-m-Mentha-1,8-diene | C10H16 | 136.23 | CC1=CCCC(C1)C(=C)C |
| TCMBANKIN018177 | lysimachoside | CCCC1OCC23CCC(CC2C4=CCC5C6(CCC(C(C6CCC5(C4(CC3O1)C)C)(C)C)OC7C(C(C(CO7)OC8C(C(C(C(O8)CO)O)O)OC9C(C(C(CO9)O)O)O)O)OC1C(C(C(C(O1)CO)O)O)O)C)(C)CO | |||
| TCMBANKIN021215 | jujuboside B_qt | C52H84O21 | 1045.21 | ||
| TCMBANKIN021808 | juzunal | SCHEMBL16226525; 3,5-dihydroxy-1-methoxy-9,10-dioxoanthracene-2-carbaldehyde; AC1NSX8M | C16H10O6 | 298.25 g/mol | COC1=C2C(=CC(=C1C=O)O)C(=O)C3=C(C2=O)C=CC=C3O |
| TCMBANKIN023180 | Spiradine A | spiradine a | C20H25NO2 | 311.42 | CC12CCCC34C1C5(CC67C3C(=O)C(CC6C4N5C2)C(=C)C7)O |
| TCMBANKIN024937 | 6'''-p-coumaroylspinosin | C38H40O17 | CC1=CC2=C(C(=O)C=C(O2)C3=CC=C(C=C3)O)C(=C1C4C(C(C(C(O4)CO)O)O)OC5C(C(C(C(O5)COC(=O)C=CC6=CC(=C(C=C6)O)OC)O)O)O)O | ||
| TCMBANKIN025303 | convallarin | ||||
| TCMBANKIN026167 | phytosterol | 414.79 | |||
| TCMBANKIN027536 | convallamarin | 1391-12-4 | C57H94O27 | 1211.3 g/mol | CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3CC(CC4C3(C5CCC6C(C5CC4)CC7C6(C(C(O7)(CCC(=C)COC8C(C(C(C(O8)CO)O)O)O)O)C)C)C)OC9C(C(C(C(O9)C)OC1C(C(C(C(O1)CO)O)O)O)O)O)C)O)O)O |
| TCMBANKIN028887 | Jujubogenin | jujubogenin | C30H48O4 | 472.7 | CC(=CC1CC(C2C3CCC4C5(CCC(C(C5CCC4(C36CC2(O1)OC6)C)(C)C)O)C)(C)O)C |
| TCMBANKIN030271 | Jujuboside C | jujuboside c | C59H96O27 | 1237.38 | CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC6C7C(CC(OC78CC6(C5(CCC4C3(C)C)C)CO8)C=C(C)C)(C)O)C)O)OC9C(C(C(C(O9)COC1C(C(C(C(O1)CO)O)O)O)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)O |
| TCMBANKIN030304 | cyclic adenosine 3',5'-monophosphate(cAMP) | 401.31 | |||
| TCMBANKIN032314 | jujuboside A_qt | C58H94O26 | 1207.35 | ||
| TCMBANKIN035108 | ebelin lactone | C30H46O3 | 454.7 g/mol | CC(=CC=CC(=CC1CCC2C3(CCC(C(C3CCC2(C14CC(=O)OC4)C)(C)C)O)C)C)C | |
| TCMBANKIN035440 | dauricine | AKOS015965146; AC-20217; SCHEMBL677474; 524-17-4 | C38H44N2O6 | 624.77 | CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC)OC |
| TCMBANKIN036734 | Jujuboside A1 | jujuboside a1 | C58H94O26 | 1207.35 | CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC6C7C(CC(OC78CC6(C5(CCC4C3(C)C)C)CO8)C=C(C)C)(C)O)C)O)OC9C(C(C(C(O9)COC1C(C(C(C(O1)CO)O)O)O)O)O)OC1C(C(C(CO1)O)O)O)O)O)O |
| TCMBANKIN036780 | (2S,3S)-N-[(1S)-1-carbamoyl-3-methyl-butyl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-formylphenoxy)-4-methyl-valeramide | (2S,3S)-N-[(1S)-1-carbamoyl-3-methyl-butyl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-formylphenoxy)-4-methyl-pentanamide; (2S,3S)-N-[(2S)-1-amino-4-methyl-1-oxo-pentan-2-yl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-methanoylphenoxy)-4-methyl-pentanamide; (2S,3S)-N-[(1S)-1-carbamoyl-3-methylbutyl]-2-[[(2S)-2-dimethylamino-1-oxo-3-phenylpropyl]amino]-3-(4-formylphenoxy)-4-methylpentanamide; (2S,3S)-N-[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]-2-[[(2S)-2-dimethylamino-3-phenylpropanoyl]amino]-3-(4-formylphenoxy)-4-methylpentanamide | C30H42N4O5 | 538.68 | |
| TCMBANKIN037988 | Polyfuroside PO8 | ||||
| TCMBANKIN038204 | ferulic acid | (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; caffeic acid 3-methyl ether; ferulicacid; A803063; (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoate; CJ-00500; ZB002373; ferulate; CHEBI:29749; (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; 3-Methoxy-4-hydroxy-trans-cinnamate; (E)-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enoate; Ferulic Acid; AC1NUT2L; ferulic acid | C10H10O4 | 194.18 | COC1=C(C=CC(=C1)C=CC(=O)O)[O-] |
| TCMBANKIN038561 | sanjoinine g2 | ||||
| TCMBANKIN038858 | sanjoinine G1 | sanjoinine g1 | C31H44N4O5 | 552.7 | CC(C)CC1C(=O)NCC(C2=CC=C(C=C2)OC(C(C(=O)N1)NC(=O)C(CC3=CC=CC=C3)N(C)C)C(C)C)O |
| TCMBANKIN040516 | Wattoside C | ||||
| TCMBANKIN040764 | Sanjoinenine | 489.61 | |||
| TCMBANKIN041901 | spinosin | (2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL (1S,4R,5R,9R,10S,13R)-13-{[(2S,3R,4S,5S,6R)-4,5-DIHYDROXY-6-(HYDROXYMETHYL)-3-{[(2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}OXAN-2-YL]OXY}-5,9-DIMETHYL-14-METHYLIDENETETRACYCLO[11.2.1.0(1),(1)?.0?,?]HEXADECANE-5-CARBOXYLATE; 6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-methylol-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-chromone; 6-(2-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyl)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4H-1-benzopyran-4-one; ZINC250859376; BG01794006; MolPort-006-131-346; SCHEMBL15521912; AKOS015840141; 6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-chromen-4-one; 6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-2-tetrahydropyranyl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-chromenone; 2''-O-beta-D-Glucopyranosylswertisin; 4H-1-Benzopyran-4-one, 6-(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-; 72063-39-9; 6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-oxan-2-yl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-chromen-4-one; Spinosin; 6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychromen-4-one | C28H32O15 | 609 | [C@@]1([H])(O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O[C@@]2([H])c3c(OC([H])([H])[H])c([H])c(OC(c4c([H])c([H])c(O[H])c([H])c4[H])=C([H])C5=O)c5c3O[H])[C@]([H])(O[H])[C@@]([ H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O1 |
| TCMBANKIN043238 | Jujuboside E | ||||
| TCMBANKIN043528 | Polyfuroside PO6 | ||||
| TCMBANKIN044120 | Polyfuroside PO7 | ||||
| TCMBANKIN044337 | sanjoinine D | sanjoinine d | C32H46N4O5 | 566.73 | CC(C)CC1C(=O)NCC(C2=CC=C(C=C2)OC(C(C(=O)N1)NC(=O)C(CC3=CC=CC=C3)N(C)C)C(C)C)OC |
| TCMBANKIN045476 | vicenin-2 | 5,7,4'-Trihydroxyflavone-6,8-di-C-glucoside; MLS000575019; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one; Apigenin-6,8-di-C-glycoside; SMR000232371; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]-4-chromenone; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]chromone; C10195; vicenin- 2; 23666-13-9; vicenin-2; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one | C27H30O15 | 595 | c1([C@]2([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])c(O[H])c(C(=O)C([H])=C(c3c([H])c([H])c(O[H])c([H])c3[H])O4)c4c([C@]5([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[ H])[C@]([H])(O[H])[C@@]5([H])O[H])c1O[H] |
| TCMBANKIN046200 | amphibine D | amphibine d | C36H49N5O5 | 631.8 | CCC(C)C1C(=O)NC=CC2=CC=C(C=C2)OC3CCN(C3C(=O)N1)C(=O)C(C(C)CC)NC(=O)C(CC4=CC=CC=C4)N(C)C |
| TCMBANKIN047304 | Jujuboside D | 1207.3 g/mol | |||
| TCMBANKIN047386 | 22-hydroxy-25(r,s)-furost-5-en-12-on-3β,22,26-triol 26-o-β-d-glucopyranoside | C33H52O10 | |||
| TCMBANKIN048748 | 3-O-beta-D-Glucopyranosyl-5,9,4`-trihydroxy-8-methoxy-flavone | C22H22O11 | 462.403 | c1([H])c(OC([H])([H])[H])c(OC(c2c([H])c([H])c(O[H])c([H])c2[H])=C(O[C@]3([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(C([H])([H])O[H])O3)C4=O)c4c(O[H])c1[H] | |
| TCMBANKIN049128 | sanjoinine F | sanjoinine f | C31H42N4O5 | 550.69 | CC(C)C1C(C(=O)NC(C(=O)NC=CC2=CC=C(O1)C=C2)C(C(C)C)O)NC(=O)C(CC3=CC=CC=C3)N(C)C |
| TCMBANKIN050145 | sanjoinine B | sanjoinine b | C30H40N4O4 | 520.66 | CC(C)CC1C(=O)NC=CC2=CC=C(C=C2)OC(C(C(=O)N1)NC(=O)C(CC3=CC=CC=C3)NC)C(C)C |
| TCMBANKIN058000 | zizyphusine | (r)-zizyphusine | C20H24NO4+ | 342.4 g/mol | C[N+]1(CCC2=CC(=C(C3=C2C1CC4=C3C(=C(C=C4)OC)OC)O)O)C |
| TCMBANKIN058468 | quercitol | MFCD06797163; (+)-Quercitol; AC1L9B61; 488-73-3; D-chiro-Inositol, 2-deoxy-; 5-Deoxyinositol; SCHEMBL6079050; CHEBI:27371; d-Quercitol; UNII-M8H1D7SDLM; 2-Deoxy-myo-inositol; ZINC4097493; Quercitol; Q0071; M8H1D7SDLM; Viburnitol; DTXSID80197609; (1R,2S,4S,5R)-cyclohexane-1,2,3,4,5-pentol; CHEMBL1950778; 1L-1,3,4/2,5-cyclohexanepentol; (+)-proto-Quercitol; C08258; Acorn sugar; d-quercitol; (+)-quercitol | C6H12O5 | 164.16 g/mol | C1C(C(C(C(C1O)O)O)O)O |
| TCMBANKIN058640 | 2-azetidinecarboxylic acid | VA80038; AKOS004910733; (2S)-(-)-Azetidine-2-carboxylic acid; CHEMBL33592; Azetidinecarboxylic acid; AK-27256; BB 0262160; FT-0634338; NSC72471; CHEBI:38108; BDBM50000108; A-2380; azetidine-2-carboxylic acid, AldrichCPR; ST1010054; azetidin-1-ium-2-carboxylate; Z1318268680; HT782; J-012991; A814215; FT-0600768; EN002094; DL-2-Azetidinecarboxylic acid; EN300-24071; EINECS 219-740-2; MFCD00066660; CTK1A3520; ACT01822; AC-5888; 4CH-013358; Q848; (RS)-AZETIDINE-2-CARBOXYLIC ACID; 20063-89-2; MCULE-1336085891; 517A046; DL-Azetidine-2-carboxylic acid; SC-53260; 4CH-011944; KB-50282; DL-AzeOH; TL80090703; CA-1879; 2-AZETIDINECARBOXYLIC ACID; (R)-azetidine-2-carboxylicacid; 2-Azetidinecarboxylicacid; DB-008923; ACMC-209yxx; AC-23581; (+)-2-AZETIDINECARBOXYLIC ACID; TL8001772; X2014; KS-00000KFF; K-0016; NSC-72471; azetidine-2-carboxylicacid; AZETIDINE-2-CARBOXYLICACID (L-); 7729-30-8 Azetidine-2-carboxylic acid; AC1NRUXC; Azetidine-2-carboxylic acid; AC-23205; azetidine-2-carboxylate; RP00426; S14-2650; (+/-)-2-AZETIDINECARBOXYLIC ACID; IADUEWIQBXOCDZ-UHFFFAOYSA-N; (RS)-2-AZIRIDINECARBOXYLIC ACID; F8887-4126; KB-47479; A9783; TX-012237; MolPort-002-471-062; SY013679; (+-)-2-Azetidinecarboxylic acid; AN-10538; AC1L29PE; AM20090145; I04-1348; ALBB-023626; QC-9589; D,L-AzeOH; I04-0055; GS-4253; BR-27256; CS-M0178; SCHEMBL122166; AC1Q74O1; DL-H-AZE-OH; 2-Azetidinecarboxylic acid, (S)- (9CI); 2517/4/6; DB-067333; 1-Azetidinecarboxylicacid, 2-(aminocarbonyl)-, 1,1-dimethylethyl ester, (2S)-; J-519619; D,L-Azetidine-2-carboxylic Acid; PB12060; AB0002316; ANW-50569;azetidine-2-carboxylic acid | C4H7NO2 | 101.1 | C1CNC1C(=O)O |
| TCMBANKIN058701 | alphitotic acid | Alphitolic acid; alphitolic acid; 2α,3β-dihydroxyl-lup-20(29)-en-28(19)-lactone; 2α,3α-dihydroxylup-20(29)-en-28-oicacid; alphitolicacid; NCGC00169506-02_C30H48O4_(2alpha,3beta,5xi,9xi,13xi,18xi)-2,3-Dihydroxylup-20(29)-en-28-oic acid | C30H48O4 | 472.7 | CC(=C)C1CCC2(C1C3CCC4C(C3(CC2)C)(CCC5C4(CC(C(C5(C)C)O)O)C)C)C(=O)O |
| TCMBANKIN058706 | betulin | AKOS025402304; Ambotz473-98-3; betulin ; AC-7983; SCHEMBL9888462; (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol; FVWJYYTZTCVBKE-MAIYTPNSSA-N; ; Trochol; 18211-63-7; C08618; Messagenin; 473-98-3; AIDS002710; B9757_SIGMA; ZINC03978650; Prestwick3_000990; Betulin; MEGxp0_001726; AI3-62999; BSPBio_001059; Lup-20(30)-ene-3beta,28-diol; C08631; Betulinol; ACon1_000091; AIDS-002710; Lup-20(29)-ene-3beta,28-diol; BPBio1_001165; Betuline; Lup-20(29)-ene-3,28-diol, (3beta)-; NSC 4644; (3.beta.)-Lup-20(29)-ene-3,28-diol; NSC692218; EINECS 207-475-5; Betulinic alcohol; ST5411404; Trochol | C30H50O2 | 442.7g/mol | CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)CO |
| TCMBANKIN059286 | polyfuroside; (25r)-26-o-β-d-glucopyranosyl-22-hydroxy-furost-5(6)-ene-3β,26-diol-3-o-β-d-glucopyra-nosyl(1→2)[β-d-glucopyranosyl(1→3)]-β-d-glucopyranosyl(1→4)-β-d-galactopyranoside | C57H94O29 | 1243.34 | CC(C1=CC=C(C=C1)S(=O)C)NC(=O)N2CC(C(C2)C(F)(F)F)C(=O)O | |
| TCMBANKIN059566 | 6-O-E-Feruloylajugol | 524.57 | CC1(CC(C2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)OC(=O)C=CC4=CC(=C(C=C4)O)OC)O | ||
| TCMBANKIN060553 | Ziyuglycoside I | C41H66O13 | 767 g/mol | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)O)C)C)C2C1(C)O)C)C(=O)OC7C(C(C(C(O7)CO)O)O)O | |
| TCMBANKIN060657 | amphibin d | C36H49N5O5 | 631.8 | CCC(C)C1C(=O)NC=CC2=CC=C(C=C2)OC3CCN(C3C(=O)N1)C(=O)C(C(C)CC)NC(=O)C(CC4=CC=CC=C4)N(C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN061340 | n-methylasimilobine | 1-Methoxy-6a-beta-Aporphin-2-ol; 16-methoxy-10-methyl-10-azatetracyclo[7.7.1.0;{2,7}.0;{13,17}]heptadeca-1(17),2,4,6,13,15-hexaen-15-ol; (-)-N-Methylasimilobine; N-Methyl-Asimilobine; 16-METHOXY-10-METHYL-10-AZATETRACYCLO[7.7.1.0(2),?.0(1)(3),(1)?]HEPTADECA-1(17),2,4,6,13,15-HEXAEN-15-OL; AKOS032949134; Floribundine; 2-hydroxy-1-methoxyaporphine; floribundine | C18H19NO2 | 281.35 | CN1CCC2=CC(=C(C3=C2C1CC4=CC=CC=C43)OC)O |
| TCMBANKIN061446 | swertisin | LMPK12110972; 7-O-Methylapigenin 6-C-beta-D-glucopyranoside; SCHEMBL2778667; 6-beta-D-Glucopyranosyl-4',5-dihydroxy-7-methoxyflavone; 3-hydroxy-4-methoxy-phenylmethol-O-β-D-glucopyranosyl-(1→6 )-β-D-glucopyranoside | C22H22O10 | 446.4 g/mol | COC1=C(C(=C2C(=C1)OC(=CC2=O)C3=CC=C(C=C3)O)O)C4C(C(C(C(O4)CO)O)O)O |
| TCMBANKIN061464 | cearoin | 2-methoxy-5-(1-phenylethenyl)benzene-1,4-diol; AC1NSTG1;BSPBio_002969; Spectrum_000592; KBio2_003640; Spectrum2_001954; SPECTRUM290030; SDCCGMLS-0066944.P001; KBio2_006208; KBio3_002189; SPBio_002047; SpecPlus_000118; Spectrum4_001597; NCGC00095562-01; KBioGR_002214; Spectrum5_000314; DivK1c_006214; KBioSS_001072; KBio1_001158; Spectrum3_001305; (2,5-dihydroxy-4-methoxy-phenyl)-phenyl-methanone; KBio2_001072;(2,5-dihydroxy-4-methoxyphenyl)-phenylmethanone | C14H12O4 | 244.24 g/mol | COC1=C(C=C(C(=C1)O)C(=O)C2=CC=CC=C2)O |
| TCMBANKIN061574 | feruloyltyramine | n- cis-feruloyltyramine; NP-001984; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; NCGC00169550-01; N-Trans-Feruloyl Tyramine; Moupinamide, >=95% (LC/MS-ELSD); 66648-43-9; Alfrutamide; trans-N-Feruloyltyramine; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; N-Feruloyltyramine; ZINC901461; MEGxp0_000693; Feruloyltyramine; Moupinamide; BRD-K98045316-001-01-0; MolPort-001-740-847; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; MCULE-4768764740; n-trans-feruloyl-tyramine; W1092; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; ACon1_001233; N-trans-Feruloyltyramine; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; CHEMBL206555; 65646-26-6; n- trans-feruloyltyramine; N-Transferuloyl Tyramine; MFCD17214811; AKOS025287596; CHEBI:17818; C02717; AC1NQX6M; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; CHEBI:17818; 3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS113439; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; N-trans-Feruloyltyramine; C02717; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; N-Feruloyltyramine; 65646-26-6; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS-113439; 66648-43-9; Feruloyltyramine; moupinamide; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; ACon1_001233; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; MEGxp0_000693; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-, (2Z)-; 80510-09-4; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; Moupinamide; n-trans-feruloyltyramine; N-E-feruloyl tyramine; n-cis-feruloyltyramine | C18H19NO4 | 313.3 g/mol | COC1=C(C=CC(=C1)C=CC(=O)NCCC2=CC=C(C=C2)O)O |
| TCMBANKIN061577 | FER | Ferulate; Coniferic acid; Cinnamic acid, 4-hydroxy-3-methoxy- (8CI); KBio1_001587; Spectrum5_000554; SDCCGMLS-0066667.P001; NCGC00094889-02; AIDS017864; 3-methoxy-4-hydroxy-trans-cinnamic acid; CCRIS 3256; trans-4-Hydroxy-3-methoxycinnamic acid; 97274-61-8; (E)-4'-Hydroxy-3'-methoxycinnamic acid; Cinnamic acid, 4-hydroxy-3-methoxy-, (E)-; SBB000326; Cinnamic acid, 4-hydroxy-3-methoxy-; NCGC00094889-03; InChI=1/C10H10O4/c1-14-9-6-7(2-4-8(9)11)3-5-10(12)13/h2-6,11H,1H3,(H,12,13; 3-(4-Hydroxy-3-methoxyphenyl)acrylic acid; SMR000112202; 4-Hydroxy-3-methoxycinnamic acid; 3-Methoxy-4-hydroxy-trans-cinnamate; Ferulic acid, trans-; 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid; Spectrum2_001394; KBio3_002388; 4-Hydroxy-3-methoxy cinnammic acid; 1135-24-6; CHEBI:17620; transferulic acid NCGC00094889-01; EINECS 208-679-7; Spectrum3_001434; NCI60_002312; NSC51986; Ferulic acid dehydrogenation homopolymer; EINECS 214-490-0; CCRIS 7575; KBio2_006872; KBio2_004304; FERULOATE; 537-98-4; Spectrum_001256; caffeic acid 3-methyl ether; 128708_ALDRICH; Cinnamic acid, 4-hydroxy-3-methoxy-, trans-; NSC 674320; 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, (E)- (9CI); MLS001066385; 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-; BSPBio_003168; NSC2821; SPBio_001408; 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, (E)-; 46278_FLUKA; (E)-Ferulic acid; (E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoic acid; 3-methoxy-4-hydroxycinnamic acid; FERULIC-ACID; SpecPlus_000547; KBioSS_001736; AIDS-017864; Spectrum4_001897; (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid; 3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid homopolymer; SPECTRUM1501017; FERULIC ACID (TRANS); 3-(4-hydroxy-3-methoxy-phenyl)acrylic acid; (E)-3-(4-hydroxy-3-methoxy-phenyl)acrylic acid; (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid; DivK1c_006643; C01494; KBioGR_002459; 3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid; NSC 51986; 3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoic acid; ferulic acid; KBio2_001736; CINNAMIC ACID,4-HYDROXY,3-METHOXY FERULIC ACID; NSC 2821; W518301_ALDRICH; (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid; Trans-ferulic acid; 3-methoxy-4-hydroxycinnamic acid | C10H10O4 | 194.18 g/mol | COC1=C(C=CC(=C1)C=CC(=O)O)O |
| TCMBANKIN061680 | Oxonuciferine | oxonuciferine; Oxonuciferine; 1,2-Dimethoxy-7H-dibenzo[de,g]quinolin-7-one; (+)-ushinsunine-beta-N-oxide; 15444-20-9; AKOS028110808; 15,16-DIMETHOXY-10-AZATETRACYCLO[7.7.1.0(2),?.0(1)(3),(1)?]HEPTADECA-1(16),2,4,6,9,11,13(17),14-OCTAEN-8-ONE; lysicamine; NSC 628003; DPBMWJXWUINLQT-UHFFFAOYSA-N; DTXSID00165628; UNII-6L30DD6R7O; AIDS008762; BRN 1486372; 7H-Dibenzo[de,g]quinolin-7-one, 1,2-dimethoxy-; 5-21-13-00382 (Beilstein Handbook Reference); 1,2-Dimethoxy-7H-dibenzo(de,g)quinolin-7-one; Noraporphin-7-one, 4,5,6,6a-tetradehydro-1,2-dimethoxy-; 7H-Dibenzo(de,g)quinolin-7-one, 1,2-dimethoxy-; MolPort-044-754-181; CHEBI:70650; D01RUH; AC1L3V30; NSC-628003; 6L30DD6R7O; NSC628003; 1,2-Dimethoxy-7H-dibenzo[de,g]quinolin-7-one #; BDBM50292452; LS-97036; 7H-Dibenzo(de,g)quinolin-7-one, 1,2-dimethoxy- (9CI); AIDS-008762; SCHEMBL2046474; CCRIS 3813; CHEMBL510090; Lysicamine | C18H13NO3 | 291.3 g/mol | COC1=C(C2=C3C(=C1)C=CN=C3C(=O)C4=CC=CC=C42)OC |
| TCMBANKIN061749 | 6'-sinapoylspinosin | 6' -Sinapoylspinosin; [(2R,3S,4S,5R,6S)-6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[2-(4-hydroxyphenyl)-7-methoxy-4-oxo-5,6-dihydrochromen-6-yl]oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate; AC1NT0EY | C39H44O19 | 800.83 | COC1=CC(=CC(=C1O)OC)C=CC(=O)OCC2C(C(C(C(O2)OC3C(C(C(OC3C4=C(C=C5C(=C4O)C(=O)C=C(O5)C6=CC=C(C=C6)O)OC)CO)O)O)O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab